Literature DB >> 17603039

Cell systems and the toxic mechanism(s) of alpha-synuclein.

Mark R Cookson1, Marcel van der Brug.   

Abstract

Mutations in the SNCA gene are causal for familial Parkinson disease/Lewy body disease. alpha-Synuclein is a small acidic protein that binds loosely to the surface of vesicles and may play a role in synaptic dynamics, although its normal function remains somewhat unclear. What is clear is that point mutations or increased expression of wild type alpha-synuclein causes disease. A great deal of literature supports the overall hypothesis that alpha-synuclein is damaging to neurons because it is inherently prone to aggregation; mutations or increased concentration of the protein both increase this tendency. An unproven, but popular, contention is that the toxic species are small oligomers that are relatively soluble, which may react with membranes to damage key processes within the cell. The details of this process, especially in determining the order of events and the requirement of particular processes in cell death, are unclear. Derangements in vesicle processing, including synaptic function, protein turnover, mitochondrial function and oxidative stress, have all been suggested to occur. Whether there is a sequence of events or whether these are interacting effects is unclear, but the outcome is to trigger cell death, by both apoptotic and non-apoptotic mechanisms depending on the system studied. In this article, we develop a framework for thinking about alpha-synuclein in terms of initiating events and secondary processes that are required to trigger neuronal dysfunction and cell death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603039      PMCID: PMC2231843          DOI: 10.1016/j.expneurol.2007.05.022

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  74 in total

1.  Identification of rotenone-induced modifications in alpha-synuclein using affinity pull-down and tandem mass spectrometry.

Authors:  Hamid Mirzaei; Jeremy L Schieler; Jean-Christophe Rochet; Fred Regnier
Journal:  Anal Chem       Date:  2006-04-01       Impact factor: 6.986

2.  Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells.

Authors:  Katsutoshi Furukawa; Michiko Matsuzaki-Kobayashi; Takafumi Hasegawa; Akio Kikuchi; Naoto Sugeno; Yasuto Itoyama; Yue Wang; Pamela J Yao; Ittai Bushlin; Atsushi Takeda
Journal:  J Neurochem       Date:  2006-04-05       Impact factor: 5.372

3.  Proteasome dysfunction in aged human alpha-synuclein transgenic mice.

Authors:  Li Chen; Mona J Thiruchelvam; Kiran Madura; Eric K Richfield
Journal:  Neurobiol Dis       Date:  2006-05-19       Impact factor: 5.996

4.  Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.

Authors:  Ira E Clark; Mark W Dodson; Changan Jiang; Joseph H Cao; Jun R Huh; Jae Hong Seol; Soon Ji Yoo; Bruce A Hay; Ming Guo
Journal:  Nature       Date:  2006-05-03       Impact factor: 49.962

5.  Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.

Authors:  Jeehye Park; Sung Bae Lee; Sungkyu Lee; Yongsung Kim; Saera Song; Sunhong Kim; Eunkyung Bae; Jaeseob Kim; Minho Shong; Jin-Man Kim; Jongkyeong Chung
Journal:  Nature       Date:  2006-05-03       Impact factor: 49.962

6.  Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection.

Authors:  M C Quilty; A E King; W-P Gai; D L Pountney; A K West; J C Vickers; T C Dickson
Journal:  Exp Neurol       Date:  2005-11-28       Impact factor: 5.330

7.  DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity.

Authors:  Wenbo Zhou; Curt R Freed
Journal:  J Biol Chem       Date:  2005-10-14       Impact factor: 5.157

8.  Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans.

Authors:  Rina Ved; Shamol Saha; Beth Westlund; Celine Perier; Lucinda Burnam; Anne Sluder; Marius Hoener; Cecilia Mp Rodrigues; Aixa Alfonso; Clifford Steer; Leo Liu; Serge Przedborski; Benjamin Wolozin
Journal:  J Biol Chem       Date:  2005-10-19       Impact factor: 5.157

9.  Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells.

Authors:  Shengli Xu; Ming Zhou; Shun Yu; Yanning Cai; Alex Zhang; Kenji Uéda; Piu Chan
Journal:  Biochem Biophys Res Commun       Date:  2006-02-07       Impact factor: 3.575

Review 10.  Pathophysiology of synuclein aggregation in Lewy body disease.

Authors:  Elizabeta B Mukaetova-Ladinska; Ian G McKeith
Journal:  Mech Ageing Dev       Date:  2005-11-16       Impact factor: 5.432

View more
  77 in total

Review 1.  NSAIDs in the treatment and/or prevention of neurological disorders.

Authors:  Parto S Khansari; Leanne Coyne
Journal:  Inflammopharmacology       Date:  2012-01-10       Impact factor: 4.473

Review 2.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

3.  Hindering of proteinopathy-induced neurodegeneration as a new mechanism of action for neuroprotectors and cognition enhancing compounds.

Authors:  S O Bachurin; A A Ustyugov; O Peters; T A Shelkovnikova; V L Buchman; N N Ninkina
Journal:  Dokl Biochem Biophys       Date:  2009 Sep-Oct       Impact factor: 0.788

4.  CSF markers of neurodegeneration in Parkinson's disease.

Authors:  Hana Přikrylová Vranová; Jan Mareš; Martin Nevrlý; David Stejskal; Jana Zapletalová; Petr Hluštík; Petr Kaňovský
Journal:  J Neural Transm (Vienna)       Date:  2010-08-21       Impact factor: 3.575

5.  Neuroprotective upregulation of endogenous α-synuclein precedes ubiquitination in cultured dopaminergic neurons.

Authors:  R E J Musgrove; A E King; T C Dickson
Journal:  Neurotox Res       Date:  2010-07-09       Impact factor: 3.911

6.  Autophagy in neurite injury and neurodegeneration: in vitro and in vivo models.

Authors:  Charleen T Chu; Edward D Plowey; Ruben K Dagda; Robert W Hickey; Salvatore J Cherra; Robert S B Clark
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 7.  On the key role played by altered protein conformation in Parkinson's disease.

Authors:  L F Agnati; E Baldelli; N Andreoli; A S Woods; V Vellani; D Marcellino; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-06-05       Impact factor: 3.575

8.  Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alpha-synuclein.

Authors:  L F Agnati; G Leo; S Genedani; L Piron; A Rivera; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

9.  A causative link between the structure of aberrant protein oligomers and their toxicity.

Authors:  Silvia Campioni; Benedetta Mannini; Mariagioia Zampagni; Anna Pensalfini; Claudia Parrini; Elisa Evangelisti; Annalisa Relini; Massimo Stefani; Christopher M Dobson; Cristina Cecchi; Fabrizio Chiti
Journal:  Nat Chem Biol       Date:  2010-01-10       Impact factor: 15.040

Review 10.  Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases.

Authors:  G Brent Irvine; Omar M El-Agnaf; Ganesh M Shankar; Dominic M Walsh
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.